Skip to main content
Clinical Trials/NCT07642765
NCT07642765RecruitingNot Applicable

Evaluation of the Relationship Between Endothelial Activation and Stress Index (EASIX) and Post-Induction Hypotension in Frail Patients Undergoing Non-Cardiac Surgery: A Prospective Observational Cohort Study

Konya City Hospital2 sites in 1 country160 target enrollmentStarted: July 1, 2026Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
160
Locations
2

Study Overview

Brief Summary

Post-induction hypotension (PIH) is a common and clinically significant hemodynamic complication following general anesthesia induction. Frail patients are particularly vulnerable due to impaired vascular reactivity and endothelial dysfunction. The Endothelial Activation and Stress Index (EASIX), calculated from routine laboratory parameters (LDH, creatinine, and platelet count), may serve as a preoperative biomarker to identify patients at risk for PIH.

This prospective observational cohort study aims to evaluate the association between preoperative EASIX score and the occurrence of post-induction hypotension in frail patients undergoing elective non-cardiac surgery under general anesthesia. A total of 160 patients with a Clinical Frailty Scale (CFS) score of 4 or above will be enrolled. Mean arterial pressure will be measured every 2 minutes for the first 15 minutes after induction. PIH is defined as MAP below 65 mmHg and/or a decrease of 20% or more from baseline.

Detailed Description

EASIX is calculated as: LDH (U/L) × Creatinine (mg/dL) / Platelet count (10⁹/L), using routine preoperative laboratory values obtained within 24 hours before surgery.

All patients will receive a standardized anesthesia induction protocol: midazolam 0.05 mg/kg, fentanyl 2 mcg/kg, propofol 2 mg/kg, and rocuronium 0.6 mg/kg intravenously, followed by endotracheal intubation after 2 minutes of mask ventilation. Anesthesia maintenance will consist of 2% sevoflurane and remifentanil 0.2 mcg/kg/min infusion.

The primary outcome is the occurrence of PIH within the first 15 minutes after induction. Secondary outcomes include the diagnostic performance of EASIX (ROC-AUC analysis) and the interaction between frailty severity and EASIX on PIH development. Multivariable logistic regression will be performed adjusting for age, sex, ASA classification, baseline MAP, antihypertensive medication use, fasting duration, and induction agent doses.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 years or older
  • Scheduled for elective non-cardiac surgery under general anesthesia
  • Clinical Frailty Scale (CFS) score of 4 or above
  • Available routine preoperative laboratory values (LDH, creatinine, platelet count) within 24 hours before surgery

Exclusion Criteria

  • Cardiac surgery
  • Emergency surgery
  • Preoperative vasopressor infusion
  • Severe hematological disease
  • Missing laboratory data required for EASIX calculation

Arms & Interventions

Frail Patients Undergoing Non-Cardiac Surgery

Adult patients aged 18 years or older with a Clinical Frailty Scale (CFS) score of 4 or above, scheduled for elective non-cardiac surgery under general anesthesia at Konya City Hospital. Preoperative EASIX score will be calculated from routine laboratory values (LDH, creatinine, platelet count) obtained within 24 hours before surgery. Post-induction hemodynamic data will be collected for the first 15 minutes after anesthesia induction.

Intervention: EASIX Score Assessment (Other)

Outcomes

Primary Outcomes

Not specified

Secondary Outcomes

  • Diagnostic Performance of EASIX Score for Post-Induction Hypotension(Preoperative assessment within 24 hours before surgery)
  • Interaction Between Frailty Severity and EASIX on Post-Induction Hypotension(Within the first 15 minutes after anesthesia induction)

Investigators

Sponsor
Konya City Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mustafa Aydemir

Principal Investigator

Konya City Hospital

Study Sites (2)

Loading locations...

Similar Trials